Guggenheim Capital’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Sell
84,772
-13,929
-14% -$220K 0.01% 1072
2025
Q4
$1.8M Buy
98,701
+29,691
+43% +$500K 0.01% 699
2025
Q3
$1.01M Buy
69,010
+7,478
+12% +$128K 0.01% 915
2025
Q2
$1.12M Sell
61,532
-1,959
-3% -$39.9K 0.01% 845
2025
Q1
$1.26M Sell
63,491
-4,287
-6% -$74.1K 0.01% 794
2024
Q4
$1.16M Buy
67,778
+57,000
+529% +$1.07M 0.01% 843
2024
Q3
$215K Buy
+10,778
New +$168K ﹤0.01% 1745
2016
Q3
Sell
-29,747
Closed -$177K 2883
2016
Q2
$177K Buy
29,747
+7,929
+36% +$55.5K ﹤0.01% 2684
2016
Q1
$177K Buy
21,818
+4,286
+24% +$24.5K ﹤0.01% 2701
2015
Q4
$142K Sell
17,532
-787
-4% -$7.08K ﹤0.01% 2811
2015
Q3
$153K Buy
+18,319
New +$169K ﹤0.01% 2769

Other funds holding ADMA